<Suppliers Price>

NHS-PEG4-(m-PEG4)3-ester

Names

[ CAS No. ]:
1333154-70-3

[ Name ]:
NHS-PEG4-(m-PEG4)3-ester

[Synonym ]:
4,11,14,17,20-Pentaoxa-7,23-diazaoctacosan-1-amide, 28-[(2,5-dioxo-1-pyrrolidinyl)oxy]-8,24,28-trioxo-6,6-bis(5-oxo-2,9,12,15,18-pentaoxa-6-azanonadec-1-yl)-N-3,6,9,12-tetraoxatridec-1-yl-
MFCD22683277
28-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-8,24,28-trioxo-6,6-bis(15-oxo-2,5,8,11,18-pentaoxa-14-azanonadecan-19-yl)-N-(2,5,8,11-tetraoxatridecan-13-yl)-4,11,14,17,20-pentaoxa-7,23-diazaoctacosan-1-amide

Biological Activity

[Description]:

NHS-PEG4-(m-PEG4)3-ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> PROTAC >> PROTAC Linker

[Target]

PEGs


[In Vitro]

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].

[References]

[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Molecular Formula ]:
C60H110N6O28

[ Molecular Weight ]:
1363.539

[ Exact Mass ]:
1362.736816

[ LogP ]:
-8.37

[ Index of Refraction ]:
1.515

Related Compounds